posted by on Dec 3
The makers of Yasmin and its sister drug Yaz, are being sued in a Yasmin Lawsuit. Teva Pharmaceuticals, the makers of the generic version of the drug called Ocella, are also being sued. Yasmin is an oral contraceptive and the active ingredients are drospirenone and ethinyl estradiol.
How does Yasmin work? Drospirenone and ethinyl estradiol prevent ovulation and cause the cervical and uterine lining. These changes make it harder for sperm to reach the eggs, and harder for fertilized eggs to attach to the uterus.
Yasmin birth control is used as a contraceptive, acne treatment, and as treatment for premenstrual dysphoric disorder (PMDD), commonly known as severe PMS. It’s been on the market since 2001, and its sister drug called Yaz, was approved in 2006.
So what’s the problem with Yasmin and Yaz? People claim they cause strokes, and they are suing Bayer Healthcare Pharmaceuticals. Already more than 125 cases have come into their New Jersey Headquarters, with around six new cases every day. The Yasmin birth control lawsuit also claims that heart attacks, deep vein thrombosis, gallbladder disease, pulmonary embolisms and death are also caused by the contraceptive, which is very widely used, especially by women under 35.
Already, Bayer Healthcare Pharmaceuticals were warned by the FDA over their tv commercials that claimed Yasmin’s ability to relieve PMS. That had not been an FDA-approved use. FDA has also cited Bayer for quality control issues in their labs.
Other contraceptives have been linked to increased risk for blood clots (Nuvaring by Schering-Plough and the Ortho Evra patch) but only Yasmin and Yaz have been linked to gallbladder problems.
A Federal case against Yaz has been prepared for pretrial proceedings in an MDL (multidistrict litigation) in East St. Louis. The same is underway in New Jersey and Pennsylvania. In New Jersey, you have until December 31 2009 to offer input.